Rezvoglar KwikPen 100 [iU]/mL
Insulin glargine-aglr · INJECTION, SOLUTION · Eli Lilly and Company
No Recall HistoryCurrently in Shortage
Plain English
Rezvoglar KwikPen is a injection, solution containing insulin glargine-aglr at 100 [iU]/mL, taken subcutaneous. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Rezvoglar KwikPen
- Generic Name
- Insulin glargine-aglr
- NDC Code (Product)
0002-8980- Manufacturer
- Eli Lilly and Company
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761215
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 12/17/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Rezvoglar KwikPen used for?
Rezvoglar KwikPen contains Insulin glargine-aglr. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Rezvoglar KwikPen a controlled substance?
Rezvoglar KwikPen is not classified as a controlled substance by the DEA.
What is the generic name for Rezvoglar KwikPen?
The generic name for Rezvoglar KwikPen is Insulin glargine-aglr. There are 1 other brand versions of Insulin glargine-aglr.
What is the NDC code for Rezvoglar KwikPen 100 [iU]/mL?
The NDC (National Drug Code) for Rezvoglar KwikPen 100 [iU]/mL is 0002-8980, listed by Eli Lilly and Company.